HB 2216
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, makes various changes to the prescription drug donation repository program operated by the department of health, including transferring control of the program over to the board of pharmacy and other changes. - Amends TCA Title 56; Title 63 and Title 68.
|
Jan 31 2022 |
Assigned To S/C Health Subcommittee
Feb 07 2022
|
SB 2141
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, makes various changes to the prescription drug donation repository program operated by the department of health, including transferring control of the program over to the board of pharmacy and other changes. - Amends TCA Title 56; Title 63 and Title 68.
|
Jan 31 2022 |
Assigned To S/C Health Subcommittee
Feb 07 2022
|
HB 1022
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, enacts the "Safe, Low-Cost Prescription Drugs Program Act." - Amends TCA Title 4; Title 53; Title 68 and Title 71.
|
Feb 10 2021 |
Withdrawn.
Feb 24 2021
|
SB 1253
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, requires the board of pharmacy and the board for licensing health care facilities to promulgate rules to establish certain guidelines for pharmacies and facilities to provide for disposal of unused controlled substances and prescription drugs. - Amends TCA Title 4; Title 63 and Title 68.
|
Feb 11 2021 |
Passed On Second Consideration, Refer To Senate Health And Welfare Committee
Feb 22 2021
|
SB 1938
(111th Regular Session (2019-2020))
Drugs, Prescription - As enacted, creates provisions related to prescribing buprenorphine. - Amends TCA Title 53, Chapter 11.
|
Jan 28 2020 |
Effective Date(S) 08/01/2020
Jul 22 2020
|
HB 1980
(111th Regular Session (2019-2020))
Drugs, Prescription - As enacted, creates provisions related to prescribing buprenorphine. - Amends TCA Title 53, Chapter 11.
|
Jan 28 2020 |
Comp. Became Pub. Ch. 771
Jul 22 2020
|
HB 656
(111th Regular Session (2019-2020))
Drugs, Prescription - As enacted, authorizes nonphysician healthcare providers who are otherwise permitted to prescribe Schedule II or III drugs to also prescribe a buprenorphine product for the treatment of opioid use disorder if certain requirements met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
|
Feb 04 2019 |
Comp. Became Pub. Ch. 761
Jul 02 2020
|
SB 1060
(111th Regular Session (2019-2020))
Drugs, Prescription - As enacted, authorizes nonphysician healthcare providers who are otherwise permitted to prescribe Schedule II or III drugs to also prescribe a buprenorphine product for the treatment of opioid use disorder if certain requirements met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
|
Feb 04 2019 |
Effective Date(S) 07/01/2020
Jul 02 2020
|
HB 2287
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, permits, to the extent allowed by federal law, a healthcare provider to dispense an epinephrine auto-injector to a person without a prescription. - Amends TCA Title 39, Chapter 17; Title 49, Chapter 50, Part 16; Title 53; Title 63 and Title 68.
|
Feb 03 2020 |
Taken Off Notice For Cal. In Health Committee
Jun 02 2020
|
SB 2579
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, permits, to the extent allowed by federal law, a healthcare provider to dispense an epinephrine auto-injector to a person without a prescription. - Amends TCA Title 39, Chapter 17; Title 49, Chapter 50, Part 16; Title 53; Title 63 and Title 68.
|
Feb 03 2020 |
Taken Off Notice For Cal. In Health Committee
Jun 02 2020
|
SB 2542
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, increases from a 30-day supply to a 90-day supply the possible prescription for opioids or benzodiazepines for a patient who suffers from long-term chronic pain, as defined by the department of health by rule, if deemed appropriate by the patient's prescriber. - Amends TCA Title 4; Title 33; Title 34; Title 36; Title 37; Title 39; Title 40; Title 41; Title 49; Title 50; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Feb 05 2020 |
Taken Off Notice For Cal. In Health Committee
Jun 02 2020
|
HB 2681
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, increases from a 30-day supply to a 90-day supply the possible prescription for opioids or benzodiazepines for a patient who suffers from long-term chronic pain, as defined by the department of health by rule, if deemed appropriate by the patient's prescriber. - Amends TCA Title 4; Title 33; Title 34; Title 36; Title 37; Title 39; Title 40; Title 41; Title 49; Title 50; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Feb 05 2020 |
Taken Off Notice For Cal. In Health Committee
Jun 02 2020
|
SB 1939
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $100. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.
|
Jan 28 2020 |
Taken Off Notice For Cal. In Insurance Committee
Jun 01 2020
|
SB 1935
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, increases the notice period, from 30 to 45 days before the effective date, by which a covered entity or pharmacy benefits manager must disclose to a pharmacy or pharmacist in its network any material change to a contract provision that affects the terms of reimbursement, the process for verifying benefits and eligibility, the dispute resolution procedure, the procedure for verifying drugs included in the formulary, and the procedure for contract termination. - Amends TCA Title 8; Title 33; Title 53; Title 56; Title 63 and Title 71.
|
Jan 23 2020 |
Taken Off Notice For Cal. In Insurance Committee
Jun 01 2020
|
HB 1866
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, increases the notice period, from 30 to 45 days before the effective date, by which a covered entity or pharmacy benefits manager must disclose to a pharmacy or pharmacist in its network any material change to a contract provision that affects the terms of reimbursement, the process for verifying benefits and eligibility, the dispute resolution procedure, the procedure for verifying drugs included in the formulary, and the procedure for contract termination. - Amends TCA Title 8; Title 33; Title 53; Title 56; Title 63 and Title 71.
|
Jan 23 2020 |
Taken Off Notice For Cal. In Insurance Committee
Jun 01 2020
|
HB 1931
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $100. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.
|
Jan 28 2020 |
Taken Off Notice For Cal. In Insurance Committee
Jun 01 2020
|
SB 2377
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, enacts the "Modernizing Medication Utilization Act." - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Feb 05 2020 |
Action Deferred In Senate Commerce & Labor Committee
Mar 17 2020
|
HB 2688
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, enacts the "Modernizing Medication Utilization Act." - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Feb 05 2020 |
Action Deferred In Senate Commerce & Labor Committee
Mar 17 2020
|
HB 1649
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, requires physicians, dentists, nurses, podiatrists, optometrists, physician assistants, and pharmacists to explain to a patient any side effects of a prescribed drug prior to prescribing or dispensing the drug; provides an exception for drugs prescribed or dispensed to patients on a recurring basis; designates a failure to comply as professional misconduct and subjects the prescriber or pharmacist to discipline by the prescriber's or pharmacist's licensing authority. - Amends TCA Title 53; Title 63 and Title 68.
|
Jan 15 2020 |
Passed On Second Consideration, Refer To Senate Health And Welfare Committee
Feb 10 2020
|
SB 2792
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, requires physicians, dentists, nurses, podiatrists, optometrists, physician assistants, and pharmacists to explain to a patient any side effects of a prescribed drug prior to prescribing or dispensing the drug; provides an exception for drugs prescribed or dispensed to patients on a recurring basis; designates a failure to comply as professional misconduct and subjects the prescriber or pharmacist to discipline by the prescriber's or pharmacist's licensing authority. - Amends TCA Title 53; Title 63 and Title 68.
|
Jan 15 2020 |
Passed On Second Consideration, Refer To Senate Health And Welfare Committee
Feb 10 2020
|
